AT
Andrew Tsai Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
61%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
70.6%
Neutral
29.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Real Estate
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Real Estate
Real Estate Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $245 |
32%
upside
| 2 | +37% |
0
%
| 3 Feb ‘26 2 months ago |
|
|
|
Buy
Initiated
| $30 |
33%
upside
| 1 | +6.2% |
0
%
| 30 Jan ‘26 2 months ago |
|
|
|
Hold
Downgraded
| $0.9000 |
52%
upside
| 1 | – |
–
| 17 Dec ‘25 4 months ago |
|
|
|
Hold
Initiated
| $30 |
41%
downside
| 1 | – |
–
| 12 Dec ‘25 4 months ago |
|
|
|
Buy
Maintained
| $450 |
31%
upside
| 2 | +192% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Buy
Initiated
| $32 |
8%
upside
| 1 | +51% |
0
%
| 21 Nov ‘25 5 months ago |
|
|
|
Buy
Maintained
| $25 |
2%
upside
| 1 | +82% |
0
%
| 12 Nov ‘25 5 months ago |
|
|
|
Hold
Downgraded
| $20 |
8%
downside
| 1 | – |
–
| 22 Oct ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $56 |
2%
upside
| 1 | – |
–
| 9 Oct ‘25 6 months ago |
|
|
|
Buy
Initiated
| $190 |
3%
upside
| 1 | +34% |
0
%
| 25 Sep ‘25 7 months ago |
|
|
|
Buy
Maintained
| $35 |
72%
upside
| 2 | -19% |
0
%
| 24 Jul ‘25 9 months ago |
|
|
|
Buy
Initiated
| $30 |
12%
downside
| 1 | +175% |
0
%
| 18 Jul ‘25 9 months ago |
|
|
|
Buy
Initiated
| $70 |
4%
downside
| 1 | +53% |
0
%
| 14 Jul ‘25 9 months ago |
|
|
|
Buy
Maintained
| $110 |
3%
upside
| 1 | +23% |
0
%
| 11 Jun ‘25 10 months ago |
|
|
|
Hold
Downgraded
| $2.50 |
29%
downside
| 1 | -80% |
–
| 28 May ‘25 11 months ago |
|